Special Issues

Special Issues

We bring you special features throughout the year to enhance the depth of our hematology and oncology coverage

March 2021 Special Edition

This supplement discusses new immunotherapies for myeloma, the role of transplant in treating patients with peripheral T-cell lymphomas, and more.

Focus on Classical Hematology (Volume 6, Issue 12.1)

This supplement takes a look at new guidelines for the treatment of TTP, the latest FDA approvals for the treatment of red blood cell and iron disorders, and more.

Focus on Myeloid Malignancies (Volume 6, Issue 6.1)

This supplement discusses the value of mutation testing for myeloid malignancies, reevaluates maintenance therapy in AML, and more.

Focus on Lymphoid & Plasma Cell Malignancies (Volume 6, Issue 4.1)

This supplement takes a look at the future of chemoimmunotherapy for chronic lymphocytic leukemia, the latest FDA approvals for the treatment of lymphoid and plasma cell malignancies, and more.

Focus on Classical Hematology (Volume 5, Issue 12.1)

This supplement explores new treatment options for hemophilia, gene therapy in nonmalignant hematologic disorders, and more.

Focus on Myeloid Malignancies (Volume 5, Issue 6.1)

This supplement features FDA updates for the treatment of myeloid malignancies, new questions in acute myeloid leukemia, and more.

Focus on Lymphoid Malignancies (Volume 5, Issue 4.1)

This supplement features a look at the future of Hodgkin lymphoma treatment, the latest approvals for lymphoid malignancies, and more.

Focus on Classical Hematology (Volume 4, Issue 12.1)

In this special edition, we take a look at the latest updates in classical hematology, from a advances in gene therapy for hemophilia to a debate about intravenous iron in pregnant women with iron-deficiency anemia, and more.

Focus on Myeloid Malignancies (Volume 4, Issue 6.1)

This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.

Focus on Lymphoma & Myeloma (Volume 4, Issue 4.1)

This supplement features a look at controversies in myeloma treatment, the future of immunotherapy for lymphoma, newly approved and investigational therapies, and more.
Advertisement

Current Issue

March 2021 Volume 7 Issue 4

This issue examines the 21st Century Cures Act’s information blocking requirements, blood services around the globe, and more.

Block title